These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11805137)

  • 1. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation.
    Anders HJ; Vielhauer V; Frink M; Linde Y; Cohen CD; Blattner SM; Kretzler M; Strutz F; Mack M; Gröne HJ; Onuffer J; Horuk R; Nelson PJ; Schlöndorff D
    J Clin Invest; 2002 Jan; 109(2):251-9. PubMed ID: 11805137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.
    Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ
    Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease.
    Ninichuk V; Gross O; Reichel C; Khandoga A; Pawar RD; Ciubar R; Segerer S; Belemezova E; Radomska E; Luckow B; Perez de Lema G; Murphy PM; Gao JL; Henger A; Kretzler M; Horuk R; Weber M; Krombach F; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 Apr; 16(4):977-85. PubMed ID: 15716328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction.
    Eis V; Luckow B; Vielhauer V; Siveke JT; Linde Y; Segerer S; Perez De Lema G; Cohen CD; Kretzler M; Mack M; Horuk R; Murphy PM; Gao JL; Hudkins KL; Alpers CE; Gröne HJ; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2004 Feb; 15(2):337-47. PubMed ID: 14747380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice.
    Anders HJ; Belemezova E; Eis V; Segerer S; Vielhauer V; Perez de Lema G; Kretzler M; Cohen CD; Frink M; Horuk R; Hudkins KL; Alpers CE; Mampaso F; Schlöndorff D
    J Am Soc Nephrol; 2004 Jun; 15(6):1504-13. PubMed ID: 15153561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with BX471, a CC chemokine receptor 1 antagonist, attenuates systemic inflammatory response during sepsis.
    He M; Horuk R; Moochhala SM; Bhatia M
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1173-80. PubMed ID: 17234893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with BX471, a nonpeptide CCR1 antagonist, protects mice against acute pancreatitis-associated lung injury by modulating neutrophil recruitment.
    He M; Horuk R; Bhatia M
    Pancreas; 2007 Mar; 34(2):233-41. PubMed ID: 17312463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice.
    Lange-Sperandio B; Trautmann A; Eickelberg O; Jayachandran A; Oberle S; Schmidutz F; Rodenbeck B; Hömme M; Horuk R; Schaefer F
    Am J Pathol; 2007 Sep; 171(3):861-71. PubMed ID: 17675578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine receptor CCR1: a new target for progressive kidney disease.
    Ninichuk V; Anders HJ
    Am J Nephrol; 2005; 25(4):365-72. PubMed ID: 16088077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice.
    Ninichuk V; Khandoga AG; Segerer S; Loetscher P; Schlapbach A; Revesz L; Feifel R; Khandoga A; Krombach F; Nelson PJ; Schlöndorff D; Anders HJ
    Am J Pathol; 2007 Apr; 170(4):1267-76. PubMed ID: 17392166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists.
    Anders HJ; Ninichuk V; Schlöndorff D
    Kidney Int; 2006 Jan; 69(1):29-32. PubMed ID: 16374420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C5 mediates experimental tubulointerstitial fibrosis.
    Boor P; Konieczny A; Villa L; Schult AL; Bücher E; Rong S; Kunter U; van Roeyen CR; Polakowski T; Hawlisch H; Hillebrandt S; Lammert F; Eitner F; Floege J; Ostendorf T
    J Am Soc Nephrol; 2007 May; 18(5):1508-15. PubMed ID: 17389734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wen-pi-tang-Hab-Wu-ling-san reduces ureteral obstructive renal fibrosis by the reduction of oxidative stress, inflammation, and TGF-beta/Smad2/3 signaling.
    Jung KJ; Kim J; Park YK; Yoon YR; Park KM
    Food Chem Toxicol; 2010 Feb; 48(2):522-9. PubMed ID: 19913069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model.
    Menu E; De Leenheer E; De Raeve H; Coulton L; Imanishi T; Miyashita K; Van Valckenborgh E; Van Riet I; Van Camp B; Horuk R; Croucher P; Vanderkerken K
    Clin Exp Metastasis; 2006; 23(5-6):291-300. PubMed ID: 17086356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis.
    Surendran K; Schiavi S; Hruska KA
    J Am Soc Nephrol; 2005 Aug; 16(8):2373-84. PubMed ID: 15944336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
    Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
    Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes.
    Vielhauer V; Anders HJ; Mack M; Cihak J; Strutz F; Stangassinger M; Luckow B; Gröne HJ; Schlöndorff D
    J Am Soc Nephrol; 2001 Jun; 12(6):1173-1187. PubMed ID: 11373340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
    Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage infiltration and renal damage are independent of matrix metalloproteinase 12 in the obstructed kidney.
    Abraham AP; Ma FY; Mulley WR; Ozols E; Nikolic-Paterson DJ
    Nephrology (Carlton); 2012 May; 17(4):322-9. PubMed ID: 22257277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E ameliorates renal fibrosis by inhibition of TGF-beta/Smad2/3 signaling pathway in UUO mice.
    Tasanarong A; Kongkham S; Duangchana S; Thitiarchakul S; Eiam-Ong S
    J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S1-9. PubMed ID: 22619900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.